| Literature DB >> 26081438 |
Zhi-Wei Jiao1, Yong-Qiang Tu2, Qing Zhang1, Wen-Xing Liu1, Shu-Yu Zhang1, Shao-Hua Wang1, Fu-Min Zhang1, Sen Jiang1.
Abstract
Natural products are a vital source of lead compounds in drug discovery. Development of efficient tandem reactions to build useful compounds and apply them to the synthesis of natural products is not only a significant challenge but also an important goal for chemists. Here we describe a tandem C-H oxidation/cyclization/rearrangement of isochroman-derived allylic silylethers, promoted by DDQ and InCl3. This method allows the efficient construction of tricyclic benzoxa[3.2.1]octanes with a wide substrate scope. We employ this tandem reaction to achieve the asymmetric total syntheses of (-)-brussonol and (-)-przewalskine E.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26081438 PMCID: PMC4557391 DOI: 10.1038/ncomms8332
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Figure 1Representative natural products containing benzoxa[3.2.1]octane skeleton and approaches to it.
(a) Selected bioactive natural products having benzoxa[3.2.1]octane skeleton. (b) Previous methods for construction of benzoxa[3.2.1]octane skeleton. (c) Our synthetic proposal via a tandem C–H oxidation/cyclization/rearrangement reaction.
Conditions optimization*.
Figure 2Reaction scope*.
*All reactions unless notified were performed in experimental section procedure on a 0.1–1.5 mmol substrate scale in CH2Cl2 (0.1 mmol ml−1), 0.1 equiv. InCl3, 4 Å MS (50 mg per 0.1 mmol), 2.0 equiv. DDQ, 5.0 equiv. DBP at RT. Relative configuration of the products were assigned based on X-ray structure of 2h and 2j (CCDC 1000811, CCDC 1000827, See Supplementary Data 2 and 3 for more details). **Isolated yields. ***1.1 equiv. DDQ was used.
Figure 3Retrosynthetic analysis of 3a,b.
The current method was used to construct the core framework.
Figure 4Asymmetric total synthesis of (−)-przewalskine E (3a) and (−)-brussonol (3b).
Reagent and conditions: (a) n-BuLi, Et2O, −78 °C, then DMF; (b) 1,3-propanediol, CH(OEt)3, (n-Bu)4N+Br3-, 65 °C; 77% (2 steps); (c) n-BuLi, Hexane/Et2O, RT, then CH2O in THF, −78 °C; (d) Ph3P, CBr4, CH2Cl2, 0 °C, 41% (2 steps); (e) (i) Zn, THF, 0 °C to RT, then Pd(Ph3P)2Cl2, 3i in DMF, 90 °C; (ii) 4 mol l−1 HCl, THF/H2O (4:1), 69% (2 steps); (f) DIBAL-H, CH2Cl2, −78 °C to RT, 93%; (g) (−)-DET, Ti(i-PrO)4, t-BuO2H, −25 °C to −50 °C, CH2Cl2, 90% yield, 83% ee; (h) DMSO, DIPEA, SO3·Py, CH2Cl2;(i) Ph3PCH3Br, t-BuOK, Tol, 72% (2 steps); (j) TBSOTf, Et3N, CH2Cl2, 0 °C to 40 °C, 98%; (k) 4 Å MS, 2,6-DBP, InCl3, DDQ, CH2Cl2, RT, 82%; (l) Ph3PCH3Br, t-BuOK, Toluene, 88%; (m) Et2Zn, CH2I2, Tol., 58%; (n) Pt2O, H2 (1 atm), AcOH, 65 °C, 89%; (o) EtSH, NaH, DMF, 150 °C, 76%; (p) Ag2O, Et2O, RT, 71%. DIPEA, N,N-diisopropylethylamine.
Figure 5Proposed mechanism.
(a) Tandem C–H bond oxidation/cyclization/semipinacol rearrangement reaction; (b) tandem C–H bond oxidation/[3,3]-Cope rearrangement/aldol reaction.